Pharmaceutical companies are facing pressure to submit all data from clinical trials to a central registry
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Frantz, S. Calls for full disclosure of clinical trials. Nat Rev Drug Discov 3, 635–636 (2004). https://doi.org/10.1038/nrd1485
Issue Date:
DOI: https://doi.org/10.1038/nrd1485
This article is cited by
-
Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers
The European Journal of Health Economics (2006)
-
Industry money skews drug overviews
Nature (2005)